Home >> Chemicals Listing >> hot product list by 3  

3,5-Pyrazolidinedione,4-(3-methyl-2-buten-1-yl)-1,2-diphenyl- (30748-29-9)

Identification
Name:3,5-Pyrazolidinedione,4-(3-methyl-2-buten-1-yl)-1,2-diphenyl-
Synonyms:3,5-Pyrazolidinedione,4-(3-methyl-2-butenyl)-1,2-diphenyl- (8CI,9CI);4-(2-Isopentenyl)-1,2-diphenyl-3,5-pyrazolidinedione;4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione;4-Prenyl-1,2-diphenyl-3,5-dioxopyrazolidine;4-Prenyl-1,2-diphenyl-3,5-pyrazolidinedione;Analud;DA 2370;Fenilprenazone;Feprazone;Methrazone;Metrazone;Phenylprenazone;Pheprazone;Prenazone;Zepelin;
CAS:30748-29-9
EINECS: 250-324-3
Molecular Formula: C20H20N2O2
Molecular Weight: 320.38
InChI: InChI=1/C20H20N2O2/c1-15(2)13-14-18-19(23)21(16-9-5-3-6-10-16)22(20(18)24)17-11-7-4-8-12-17/h3-13,18H,14H2,1-2H3
Molecular Structure: (C20H20N2O2) 3,5-Pyrazolidinedione,4-(3-methyl-2-butenyl)-1,2-diphenyl- (8CI,9CI);4-(2-Isopentenyl)-1,2-diphenyl-...
Properties
Flash Point: 178.7°C
Boiling Point: 437.2°Cat760mmHg
Density:1.174g/cm3
Refractive index:1.599
Specification:

 The 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione with the cas number 30748-29-9, is also called (1) 1,2-Diphenyl-4-(3-methyl-2-butenyl)-3,5-pyrazolidinedione; (2) 3,5-Pyrazolidinedione, 4-(3-methyl-2-butenyl)-1,2-diphenyl- ; (3) 4-(2-Isopentenyl)-1,2-diphenyl-3,5-pyrazolidinedione ; (4) 4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione ; (5) 4-(beta-Isoamylenyl)-1,2-diphenyl-3,5-pyrazolidinedione ; (6) 4-Prenyl-1,2-diphenyl-3,5-dioxopyrazolidine ; (7) 4-Prenyl-1,2-diphenyl-3,5-pyrazolidinedione ; (8) Analud ; (9) Fenilprenazone ; (10) Feprazona ; (11) Feprazona [INN-Spanish] ; (12) Feprazone ; (13) Feprazonum ; (14) Feprazonum [INN-Latin] ; (15) Methrazone ; (16) Phenylprenazone ; (17) Pheprazone ; (18) Prenazone ; (19) UNII-7BVX6J0CGR ; (20) Zepelin 

Properties of 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione are: (1)ACD/BCF (pH 5.5): 163.78 ; (2)ACD/BCF (pH 7.4): 7.64 ; (3)ACD/KOC (pH 5.5): 1215.59 ; (4)ACD/KOC (pH 7.4): 56.68 ; (5)#H bond acceptors: 4 ; (6)#H bond donors: 0 ; (7)#Freely Rotating Bonds: 4 ; (8)Polar Surface Area: 40.62Å2 ; (9)Index of Refraction: 1.599 ; (10)Molar Refractivity: 93.24 cm3 ; (11)Molar Volume: 272.7 cm3 ; (12)Polarizability: 36.96× 10-24cm3 ; (13)Surface Tension: 46.8 dyne/cm ; (14)Density: 1.174 g/cm3 ; (15)Flash Point: 178.7 °C ; (16)Enthalpy of Vaporization: 69.38 kJ/mol ; (17)Boiling Point: 437.2 °C at 760 mmHg ; (18)Vapour Pressure: 7.62E-08 mmHg at 25°C

The 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione is applicable for treat with rheumatoid arthritis, rheumatoid arthritis, ankylosing arthritis, scapulohumeral periarthritis, thrombophlebitis, Myofibrositis, dentinum phlogosis, sciatica, etc. There may be side effect such as rash, drowsiness, edema, etc, and the one who with liver and kidney damage.

You can still convert the following datas into molecular structure :
1. SMILES: O=C2N(c1ccccc1)N(C(=O)C2C\C=C(/C)C)c3ccccc3
2. InChI: InChI=1/C20H20N2O2/c1-15(2)13-14-18-19(23)21(16-9-5-3-6-10-16)22(20(18)24)17-11-7-4-8-12-17/h3-13,18H,14H2,1-2H3

The 4-Phenyl-1,2-diphenyl-3,5-pyrazolidine-dione toxic data can be showed in the following sheet.

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral > 2gm/kg (2000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH		 Yakkyoku. Pharmacy. Vol. 33, Pg. 233, 1982.
mouse LD50 intraperitoneal 270mg/kg (270mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
mouse LD50 intravenous 180mg/kg (180mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 22, Pg. 196, 1972.
mouse LD50 oral 1067mg/kg (1067mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 22, Pg. 196, 1972.
mouse LDLo subcutaneous 374mg/kg (374mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
rat LD50 intraperitoneal 362mg/kg (362mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
rat LD50 oral 1343mg/kg (1343mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 133, 1979.
rat LD50 subcutaneous 386mg/kg (386mg/kg)   Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 20, Pg. 267, 1985.

Flash Point: 178.7°C
Safety Data
 

Other Product